SWEDRES 2004 Figures and Tables. SWEDRES 2004 Table 3.1.1 Total use of antobacterial drugs in Sweden 1995-2004 DDD/1000/day Data source: The National.

Slides:

Advertisements

Similar presentations

Surveillance of antimicrobial resistance Liselotte Högberg Swedish Institute for Infectious Disease Control

Advertisements

Methicillin resistant Staphylococcus aureus (MRSA) in the Nordic countries Petter Elstrøm Advisor Norwegian Institute of Public Health.

SWEDRES 2001 Figures and Tables. 3. Use of antimicrobials.

Antimicrobial resistance surveillance in Ireland Results of invasive Staphylococcus aureus infection (blood) surveillance (2009Q1-4) **** Data as of 14/04/2010.

Antimicrobial resistance surveillance in Ireland Results of invasive Streptococcus pneumoniae infection (blood/CSF) surveillance (2009Q1-4) **** Data as.

East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.

MRSA Found in U.S. Wastewater Treatment Plants.  MRSA is a type of staph bacteria that is resistant to certain antibiotics called beta-lactams (Centers.

Discovery and development of antibiotics

The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.

Antibiogram in Washoe County Nevada – Know the Local Data, Prevent Antimicrobial Resistance Lei Chen, Ph.D., Senior Epidemiologist, Washoe County.

Antibiotic Overuse & Resistance Carolyn Bray April 11, 2006 Sponsored By: Dr. Craig Hoesley.

Antimicrobial Susceptibility Testing – Part II

Performance of Fox 10 Vs Staph. aureus DHM (Sydney), Gribbles (Melb.) Used Fox 10 since Jan 05 (> 1000) Borderline strains tested for mecA gene Results:

المضادات الحيوية.....الى أين؟ اليوم العلمي Presented by: Dalia qishawi Trends in Antimicrobial Resistance among Urinary Tract Infection Pathogens Isolated.

Antimicrobial resistance surveillance in Ireland Results of invasive Pseudomonas aeruginosa infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Surveillance report Annual Epidemiological Report on communicable diseases in Europe ECDC Surveillance Unit European Centre for Disease Prevention and.

MRSA Definition Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for difficult-to-treat infections in humans. MRSA is by definition.

The evolution of antibiotic resistance Rob Knell / Lars Chittka.

CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.

Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.

Improving Antibiotic use through a Nationwide Decentralized Project – A Nine-Year Experience Cars O, Stålsby Lundborg C, Mölstad S Swedish Strategic Programme.

Methicillin-resistant Staphylococcus Aureus - MRSA - Sharon Walker, RN, BPS Ingham County Health Department.

Antimicrobial resistance surveillance in Ireland Results of invasive Escherichia coli infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

National and International Spread of Antimicrobial Resistance: Clones and Genes Professor Alan Johnson, Health Protection Services - HPA.

National antibiotic program in the Czech Republic NAP-CZ Vlastimil Jindrák and Subcommitte for antibiotic policy ČLS JEP.

ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.

“Hand washing is the single most important means of preventing the spread of infection". -- US Centers for Disease Control.

Panton-Valentine Leukocidin (PVL) is a toxin that destroys white blood cells and is a virulence factor in some strains of Staphylococcus aureus. PVL occurs.

Antibiotic selection in the treatment of acute exacerbations of COPD Kurt A. Wargo, Pharm.D., BCPS(AQ-ID), Ryan E. Owens, Pharm.D. Candidate 2014, Takova.

Antimicrobial resistance surveillance in Ireland Results of invasive Staphylococcus aureus infection (blood) surveillance, 2009 **** Data as of 01/12/2010.

Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.

Swedres 2005 Swedres 2005 Figures and tables. Swedres 2005 Table Total use of antibacterial drugs for systemic use in Sveden , DDD/1000/day.

Interpretation/Evaluation of Laboratory Data CLS 552 Human Microbiology & Immunology Laboratory Note: View this PowerPoint as a ‘Full Screen Slide Show’.

English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.

EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015

Center for Drug Evaluation and Research March 6, 2005 Bacteremia and Endocarditis: Products and Guidance Janice Soreth, MD Director Division of Anti-Infective.

Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.

EARS-Net data on antimicrobial resistance in Ireland Quarter st March 2016.

Phage therapy for the treatment for urinary tract infection: Results of in-vitro screenings and in-vivo application using commercially available bacteriophage.

Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.

Figure 1. Rate of antimicrobial resistance in S. pneumoniae

Figure 1. Percentage of Penicillin Non-Susceptible S

Number of S, I and R to six antibiotics

EARS-Net data on Antimicrobial Resistance in Ireland, Q

Table 1 Groups of subjects in a study of the association between antibiotic use and colonization with resistant pneumococci. From: Measuring and Interpreting.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990 Niels Frimodt-Møller, Frank Espersen, Peter Skinhøj, Vibeke Thamdrup Rosdahl

ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.

Antibiotics sensitivity of microorganism causing nosocomial infections

Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times F.B. Spencker, L. Staber, T. Lietz,

E. Monee’ Carter-Griffin DNP, RN, ACNP-BC

State-wide surveillance of antibiotic resistance patterns and spa types of methicillin- resistant Staphylococcus aureus from blood cultures in North Rhine-Westphalia,

Antibiotics, prescribed for outpatients in Sweden (ATC group J01 Excluding methenamine), DDD/1000/day,

Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference.

Swedres 2007 Figures and tables Swedres 2007.

State-wide surveillance of antibiotic resistance patterns and spa types of methicillin- resistant Staphylococcus aureus from blood cultures in North Rhine-Westphalia,

Molecular characterization and susceptibility of methicillin-resistant and methicillin- susceptible Staphylococcus aureus isolates from hospitals and the.

Epidemiology of methicillin-resistant staphylococci in Europe

Strategies for managing today's infections

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

Figure 1. Percentage of Penicillin Non-Susceptible S

Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model Karl Ekdahl, Otto Cars Clinical Microbiology.

Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium Stig Harthug, A. Digranes, O. Hope, B.E. Kristiansen,

Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990 Niels Frimodt-Møller, Frank Espersen, Peter Skinhøj, Vibeke Thamdrup Rosdahl

Scottish One Health Antimicrobial Use and Resistance in 2017 Annual Report

Modification of prescribers’ behavior: the Icelandic approach

Antibiotic overconsumption and resistance in Turkey

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

EARS-Net results 2011 Ole Heuer

EARS-Net data on Antimicrobial Resistance in Ireland, Q

Presentation transcript:

SWEDRES 2004 Figures and Tables

SWEDRES 2004 Table Total use of antobacterial drugs in Sweden DDD/1000/day Data source: The National Corporation of Swedish Pharmacies

SWEDRES 2004

Table Use of tetracyclines, out-patient care 2004 DDD/1000/day and prescriptions/1000/year respectively

SWEDRES 2004

Table Total use of antibiotics within hospital care DDD/1000/day.

SWEDRES 2004

Swedres 2004, Figure 4.1. Annual PRP incidence Year Incidence per inhabitants

SWEDRES 2004 Swedres 2004, Figure 4.2. Overall national resistance rates of S.pneumoniae (resistant isolates in percent of all pneumococcal isolates) for four different antibiotics 1994–2004 (data from the annual RSQC programme, approximately 3000 isolates per year) Penicillin I+R (oxa screen) ErythromycinTetracyclineTrimethoprim- sulfonamide % R

SWEDRES 2004 Swedres 2004, Figure 4.3. Frequencies of reduced susceptibility to penicillin among invasive isolates of Streptococcus pneumoniae in Europe Data from EARSS ( ).

SWEDRES 2004 Swedres 2004, Table 4.1. Susceptibility to penicillin and erythromycin among Swedish invasive isolates of Streptococcus pneumoniae reported to EARSS.

SWEDRES 2004 Swedres 2004, Table 4.2. MRSA notified in by county according to the Commuicable Disease Act

SWEDRES 2004 No. of isolates with identical or related patterns (% of total) PFGE patternST of reference patterns UK E (9.1)76 (18.4)107 (24.4)119 (22.8)104 (16.9) DK E (17.8)54 (13.1)73 (16.7)80 (15.4)94 (15.3) Berlin IV4523 (9.5)51 (12.4)14 (3.2)63 (12.1)72 (11.7) Bel EC-3a511 (4.5)18 (4.4)30 (6.8)46 (8.8)38 (6.2) UK E (13.6)48 (11.7)41 (9.4)30 (5.8)49 (8.0) UK E1 / Spa E1 / Gr-1 239, (12.8)29 (7.0)35 (8.0)18 (3.5)20 (3.3) Fra A827 (11.2)31 (7.5)28 (6.4)20 (3.8)13 (2.1) Fra B83 (1.2)18 (4.4)16 (3.7)27 (5.2)47 (7.6) UK E354 (1.7)10 (2.4)13 (3.0)15 (2.9)29 (4.7) S German II2284 (1.7)5 (1.2)8 (1.8)7 (1.3)6 (1.0) Unrelated SE- patterns 30 (12.4)52 (12.6)62 (14.2)79 (15.2)123 (20.0) UniqueNot tested11 (4.5)20 (4.9)11 (2.5)17 (3.3)29 (4.7) Total Swedres 2004, Table 4.3. PFGE patterns of MRSA isolated in Sweden

SWEDRES 2004 Swedres 2004, Figure 4.5. Resistance rates for Staphylococcus aureus (data from the annual RSQC programme, approximately 3000 isolates per year).

SWEDRES 2004 Swedres 2004, Figure 4.6. MRSA in Europé Data from EARSS ( )

SWEDRES 2004 Swedres 2004, Table 4.4. Staphylococcus aureus susceptibility results (number of strains and percentage) using the oxacillin disk diffusion method according to SRGA in Sweden. Data reported from SMI to EARSS.

SWEDRES 2004 Swedres 2004, Figure 4.7. Annual number of VRE cases reported in Sweden.

SWEDRES 2004 Swedres 2004, Figure 4.8. Reported cases of VRE in selected counties from 2000 to 2004

SWEDRES 2004 Swedres 2004, Figure 4.9. Resistance rates of E. Faecalis, 1994, 1997, 2004, RSQC programme.

SWEDRES 2004 Swedres 2004, Figure Resistance rates (resistant isolates in percent of all Escherichia coli isolates) for six different antibiotics

SWEDRES 2004 Swedres 2004, Figure Resistance rates (% R and I) to fluoroquinolones in Escherichia coli in Europe 2004.

SWEDRES 2004 Swedres 2004, Figure Resistance rates (resistant isolates in percent of all Pseudomonas aeruginosa isolates) for six different antibiotics

SWEDRES 2004 Swedres 2004, Figure Proportion of patients with resistant TB (resistant to at least one of the first line drugs).